Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antihistamine Forced Switch To OTC Endorsed By APhA Journal Editorial

Executive Summary

A Journal of the American Pharmaceutical Association editorial endorses the forced switch of prescription antihistamines to over-the-counter status.

You may also be interested in...



Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says

QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said

Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says

QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said

Pfizer Doubts FDA Authority To Force Antihistamine OTC Switch

FDA does not have the legal authority to force an OTC switch of a prescription antihistamine, Pfizer CEO Henry McKinnell told analysts on an April 18 conference call.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel